Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol xinafoate and fluticasone propionate inhalation aerosol in adult asthma
CTR20212212Phase 3Completed
- Sponsor
- CF PharmTech
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by CF PharmTech. Started Sep 2021; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20212212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212212.